• System preventing blood clot formation in catheters

    Cathway Medical is innovating with a technology that prevents central venous catheter blockage (occlusion) due to blood clot formation

  • The Need

    Blockage, primarily due to blood clotting, is the most common noninfectious complication in long-term implanted venous catheters, which are placed to enable intravenous therapies and chronic treatments. More than 5 million venous catheters are placed every year in the United States and 1 in 4 is likely to become occluded. Occlusion requires premature catheter replacement and increases risk of morbidity and mortality among chronically treated patients.

  • Cathway Medical’s Solution

    Cathway Medical’s technology applies a novel electric-based component to the catheter, enabling deflection of clotting matter with a low level alternating electrical field and preventing occlusion.

    • Extends catheter life and function with effective drug flow for improved outcomes
    • Reduces the need for catheter replacement surgeries that increase risk to patients
    • Reduces related hospital admissions, length of stay, and associated hospital costs (surgical suite, medical teams, perioperative care)
  • Market Potential

    No similar solutions are currently in clinical use.

    • Hundreds of thousands of chronic patients are treated with long-term implanted catheters each year.
    • Potential for further clinical applications where occlusion is common, including ports for dialysis patients, arterial grafts, catheters for short-term interventional therapies, cardiac stents, peripheral stents, urinary catheters, bile stents, and even VP shunts.

Proof of concept pre-clinical trial (planned for 2021) to be followed by clinical trials with advanced product licensing agreements with large companies manufacturing and marketing advanced catheter solutions.

This site is registered on wpml.org as a development site.